Valuation: LivaNova PLC

Market Cap 4.4B 3.8B 3.58B 3.25B 6.11B 422B 6.2B 41.96B 16.44B 211B 16.53B 16.17B 703B P/E 2026 *
20.6x
P/E 2027 * 23.4x
Enterprise Value 4.48B 3.87B 3.64B 3.31B 6.22B 429B 6.31B 42.68B 16.72B 215B 16.81B 16.44B 715B EV / Sales 2026 *
2.95x
EV / Sales 2027 * 2.65x
Free-Float
98.6%
Yield 2026 *
-
Yield 2027 * -
1 day-1.99%
1 week+1.63%
Current month-0.35%
1 month-1.04%
3 months+10.56%
6 months+18.45%
Current year+29.79%
1 week 79.09
Extreme 79.09
82.7
1 month 74.67
Extreme 74.6701
85.76
Current year 56.44
Extreme 56.44
85.76
1 year 48.82
Extreme 48.82
85.76
3 years 32.48
Extreme 32.48
85.76
5 years 32.48
Extreme 32.48
93.89
10 years 32.48
Extreme 32.48
131.54
Manager TitleAgeSince
Chief Executive Officer 53 29/02/2024
Director of Finance/CFO 56 30/10/2020
Investor Relations Contact - 31/07/2022
Director TitleAgeSince
Director/Board Member 69 18/10/2015
Chairman 74 08/06/2021
Director/Board Member 62 17/06/2019
Date Insider Type Main position Quantity % Market Cap.
11/08/26 Fiscal year

Executive/Senior Manager

38,076 0.0693%
10/06/26 Other

Director

0 0%
15/12/25 Fiscal year

Executive/Senior Manager

2,350 0.0043%
Change 5-day change 1-year change 3-year change Capi.($)
-1.99%+1.63%+49.92%+47.37% 4.49B
+2.09%+2.70%-13.50%+8.65% 191B
+1.64%+1.55%-0.78%+12.97% 116B
+1.16%-5.31%+8.88%+75.24% 59.64B
-2.36%-1.19%+30.23%+63.43% 55.42B
-0.72%-0.35%-7.30%-33.95% 49.6B
+0.95%+0.08%+10.86%-15.51% 33.49B
-2.18%-2.63% - - 30.6B
-6.01%-6.73%-13.01%+17.67% 24.25B
-0.01%-1.36%+42.58%-10.62% 24.39B
Average -0.73%-0.14%+11.99%+18.36% 58.88B
Weighted average by Cap. +0.53%+0.56%+0.87%+16.73%

Financials

2026 *2027 *
Net sales 1.52B 1.31B 1.23B 1.12B 2.11B 146B 2.14B 14.49B 5.68B 72.82B 5.71B 5.58B 243B 1.63B 1.41B 1.32B 1.2B 2.26B 156B 2.29B 15.51B 6.08B 77.98B 6.11B 5.98B 260B
Net income 218M 189M 178M 161M 304M 20.93B 308M 2.08B 816M 10.47B 820M 802M 34.87B 193M 167M 157M 143M 268M 18.52B 272M 1.84B 722M 9.26B 726M 710M 30.85B
Net Debt 75M 64.78M 60.95M 55.39M 104M 7.19B 106M 715M 280M 3.59B 282M 275M 11.97B -85M -73.41M -69.07M -62.78M -118M -8.14B -120M -810M -318M -4.07B -319M -312M -13.57B
Logo LivaNova PLC
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Employees
3,300
Date Price Change Volume
18/08/26 US$79.86 -1.99% 619,120
17/08/26 US$81.48 -0.90% 445,064
14/08/26 US$82.22 +0.02% 559,434
13/08/26 US$82.20 +1.76% 677,626
12/08/26 US$80.78 +2.80% 979,119
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
79.86USD
Average target price
89.40USD
Spread / Average Target
+11.95%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LIVN Stock